Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; Results from a randomised controlled trial

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 10, 2014, Pages 1298-1305

  Bissonnette, R ^a   Nigen, S ^a   Langley, R G ^b   Lynde, C W ^c   Tan, J ^d   Fuentes Duculan, J ^e   Krueger, J G ^e  

^a INNOVADERM RESEARCH   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Lynderm Research Inc Canada   (Canada)

^d Windsor Clinical Research   (Canada)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; LEUKOCYTE ELASTASE; MESSENGER RNA; PLACEBO; USTEKINUMAB; MONOCLONAL ANTIBODY;

ACANTHOSIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOLOGY LIFE QUALITY INDEX; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PALMO PLANTAR PUSTULAR AREA AND SEVERITY INDEX; PALMO PLANTAR PUSTULAR PSORIASIS; PARAKERATOSIS; PATHOPHYSIOLOGY; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE BLIND PROCEDURE; SKIN BIOPSY; BIOPSY; CROSSOVER PROCEDURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL, HUMANIZED; BIOPSY; CROSS-OVER STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKIN-23; MALE; MIDDLE AGED; PROGNOSIS; PSORIASIS; QUALITY OF LIFE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84908087175     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12272     Document Type: Article

References (25)

1. Farley E, Masrour S, McKey J, et al,. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol 2009; 60: 1024-1031.
2. Murakami M, Ohtake T, Horibe Y, et al,. Acrosyringium is the main site of the vesicle/pustule formation in palmoplantar pustulosis. J Invest Dermatol 2010; 130: 2010-2016.
3. Mrowietz U, van de Kerkhof PC,. Management of palmoplantar pustulosis: do we need to change? Br J Dermatol 2011; 164: 942-946.
4. Chalmers R, Hollis S, Leonardi-Bee J, et al,. Interventions for chronic palmoplantar pustulosis. Cochrane Database of Syst Rev 2006; 1: CD001433.
5. Khandpur S, Sharma VK,. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis. Clin Exp Dermatol 2011; 36: 613-616.
6. Leonardi C, Sobell J, Sofen H, et al,. Phase IV study to evaluate the safety and efficacy of efalizumab for treatment of hand and foot psoriasis. In 65th Annual meeting of the American Academy of Dermatology. Washington, DC. J Am Acad Dermatol 2007; 56: AB48.
7. Bhushan M, Burden AD, McElhone K, et al,. Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2001; 145: 546-553.
8. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
9. Reilly MC, Zbrozek AS, Dukes EM,. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353-365.
10. Zaba LC, Cardinale I, Gilleaudeau P, et al,. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 2007; 204: 3183-3194.
11. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, et al,. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 2008; 181: 7420-7427.
12. Gerdes S, Franke J, Domm S, et al,. Ustekinumab in the treatment of palmoplantar pustulosis. Br J Dermatol 2010; 163: 1116-1118.
13. Chu DH, Van Voorhees AS, Rosenbach M,. Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases. Arch Dermatol 2011; 147: 1228-1230.
14. Au SC, Goldminz AM, Kim N, et al,. Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis. J Dermatolog Treat 2013; 24: 179-187.
15. Lee E, Trepicchio WL, Oestreicher JL, et al,. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004; 199: 125-130.
16. Murakami M, Hagforsen E, Morhenn V, et al,. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum. Exp Dermatol 2011; 20: 845-847.
17. Hagforsen E, Hedstrand H, Nyberg F, et al,. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis. Br J Dermatol 2010; 163: 572-579.
18. Schenkein HA, Koertge TE, Brooks CN, et al,. IL-17 in sera from patients with aggressive periodontitis. J Dent Res 2010; 89: 943-947.
19. Beklen A, Ainola M, Hukkanen M, et al,. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 2007; 86: 347-351.
20. Lillis JV, Guo CS, Lee JJ, et al,. Increased IL-23 expression in palmoplantar psoriasis and hyperkeratotic hand dermatitis. Arch Dermatol 2010; 146: 918-919.
21. Res PC, Piskin G, de Boer OJ, et al,. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS ONE 2010; 5: e14108.
22. Lin AM, Rubin CJ, Khandpur R, et al,. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011; 187: 490-500.
23. Brunasso AMG, Massone C,. Can we really separate palmoplantar pustulosis from psoriasis? J Eur Acad Dermatol Venereol 2010; 24: 619-621; author reply 21.
24. Ammoury A, El Sayed F, Dhaybi R, et al,. Palmoplantar pustulosis should not be considered as a variant of psoriasis. J Eur Acad Dermatol Venereol 2008; 22: 392-393.
25. Kingo K, Mossner R, Koks S, et al,. Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. Br J Dermatol 2007; 156: 646-652.